Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Clinical trial NCT05972135 · RECRUITING
Trial details
- NCT number
- NCT05972135
- Sponsor
- SCRI Development Innovations, LLC
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-23
- Primary completion
- 2027-08-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.